JP2023036695A5 - - Google Patents

Download PDF

Info

Publication number
JP2023036695A5
JP2023036695A5 JP2022198455A JP2022198455A JP2023036695A5 JP 2023036695 A5 JP2023036695 A5 JP 2023036695A5 JP 2022198455 A JP2022198455 A JP 2022198455A JP 2022198455 A JP2022198455 A JP 2022198455A JP 2023036695 A5 JP2023036695 A5 JP 2023036695A5
Authority
JP
Japan
Prior art keywords
compound
hydrocarbyl
different
same
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022198455A
Other languages
English (en)
Japanese (ja)
Other versions
JP7419486B2 (ja
JP2023036695A (ja
Filing date
Publication date
Priority claimed from US13/940,016 external-priority patent/US10017736B2/en
Application filed filed Critical
Publication of JP2023036695A publication Critical patent/JP2023036695A/ja
Publication of JP2023036695A5 publication Critical patent/JP2023036695A5/ja
Application granted granted Critical
Publication of JP7419486B2 publication Critical patent/JP7419486B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022198455A 2012-07-13 2022-12-13 τリン酸化を阻害する方法 Active JP7419486B2 (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201261671235P 2012-07-13 2012-07-13
US61/671,235 2012-07-13
US201361789180P 2013-03-15 2013-03-15
US61/789,180 2013-03-15
US13/940,016 2013-07-11
US13/940,016 US10017736B2 (en) 2012-07-13 2013-07-11 Method of inhibiting tau phosphorylation
JP2018189789A JP2019031520A (ja) 2012-07-13 2018-10-05 τリン酸化を阻害する方法
JP2021089538A JP2022000421A (ja) 2012-07-13 2021-05-27 τリン酸化を阻害する方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021089538A Division JP2022000421A (ja) 2012-07-13 2021-05-27 τリン酸化を阻害する方法

Publications (3)

Publication Number Publication Date
JP2023036695A JP2023036695A (ja) 2023-03-14
JP2023036695A5 true JP2023036695A5 (https=) 2023-06-26
JP7419486B2 JP7419486B2 (ja) 2024-01-22

Family

ID=49914489

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2015521820A Active JP6417324B2 (ja) 2012-07-13 2013-07-11 τリン酸化を阻害する方法
JP2018000198A Active JP6630374B2 (ja) 2012-07-13 2018-01-04 τリン酸化を阻害する方法
JP2018189789A Pending JP2019031520A (ja) 2012-07-13 2018-10-05 τリン酸化を阻害する方法
JP2021089538A Pending JP2022000421A (ja) 2012-07-13 2021-05-27 τリン酸化を阻害する方法
JP2022198455A Active JP7419486B2 (ja) 2012-07-13 2022-12-13 τリン酸化を阻害する方法

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2015521820A Active JP6417324B2 (ja) 2012-07-13 2013-07-11 τリン酸化を阻害する方法
JP2018000198A Active JP6630374B2 (ja) 2012-07-13 2018-01-04 τリン酸化を阻害する方法
JP2018189789A Pending JP2019031520A (ja) 2012-07-13 2018-10-05 τリン酸化を阻害する方法
JP2021089538A Pending JP2022000421A (ja) 2012-07-13 2021-05-27 τリン酸化を阻害する方法

Country Status (6)

Country Link
US (7) US10017736B2 (https=)
EP (1) EP2882428B1 (https=)
JP (5) JP6417324B2 (https=)
DK (1) DK2882428T3 (https=)
ES (1) ES2716049T3 (https=)
WO (1) WO2014011917A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6566867B2 (ja) * 2012-07-13 2019-08-28 ペイン セラピューティクス インコーポレイテッド 生きている患者でのアルツハイマー病アッセイ
GB201312499D0 (en) * 2013-07-12 2013-08-28 Isis Innovation Therapeutic compounds
US9433604B2 (en) 2013-10-08 2016-09-06 Pain Therapeutics Inc. Method for inhibiting growth of cancer cells
CN104030933A (zh) * 2014-05-16 2014-09-10 烟台恒迪克能源科技有限公司 一种β-异烷醇基氨基戊酸环己胺的合成方法
MA44037B1 (fr) 2016-06-06 2020-03-31 Arena Pharm Inc Modulateurs du récepteur adrénergique bêta 3 utile dans le traitement ou la prévention de troubles associés à ceux-ci
US11040935B2 (en) 2016-10-05 2021-06-22 University of Pittsburgh—of the Commonwealth System of Higher Education Small molecule AMPK activators
US12186307B2 (en) 2019-02-13 2025-01-07 Yale University Methods of treating epilepsy
CA3131146A1 (en) 2019-02-21 2020-08-27 Pain Therapeutics, Inc. Solid polymorphs of a flna-binding compound and its hydrochloride salts
EP4027987A4 (en) 2019-09-10 2023-11-29 University of Pittsburgh - Of the Commonwealth System of Higher Education Methods and materials for increasing level of phosphorylated ampk protein
JP7721130B2 (ja) * 2020-01-15 2025-08-12 国立大学法人東海国立大学機構 進行性核上性麻痺の治療
WO2022098700A1 (en) * 2020-11-03 2022-05-12 Cassava Sciences, Inc. Inhibiting an immune response mediated by one or more of tlr2, rage, ccr5, cxcr4 and cd4
CN114252324B (zh) * 2022-03-02 2022-05-13 中国人民解放军军事科学院军事医学研究院 一种方便使用的多孔脑片孵育装置
WO2024151661A2 (en) * 2023-01-10 2024-07-18 Washington University Methods of decreasing pathological neuroinflammation

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723442A (en) 1970-12-31 1973-03-27 Yoshitomi Pharmaceutical 3-oxo-1-oxa-4,8-diazaspiro(4.5)decanes
US4981858A (en) 1987-08-13 1991-01-01 State Of Israel, Represented By The Prime Minister's Office, Israel Institute For Biological Research Optical isomers
DE3853758T2 (de) 1987-10-05 1995-09-07 Yamanouchi Pharma Co Ltd Heterozyklische Spiroverbindungen und ihre Herstellung.
US5852029A (en) 1990-04-10 1998-12-22 Israel Institute For Biological Research Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
US5534520A (en) 1990-04-10 1996-07-09 Fisher; Abraham Spiro compounds containing five-membered rings
US5766846A (en) * 1992-07-10 1998-06-16 Athena Neurosciences Methods of screening for compounds which inhibit soluble β-amyloid peptide production
DE69412067T2 (de) 1993-01-28 1999-03-25 Merck & Co., Inc., Rahway, N.J. Substituierte spiro-azaringen als tachykinine rezeptor antagonisten
EP1019410A1 (en) 1995-11-23 2000-07-19 MERCK SHARP & DOHME LTD. Spiro-piperidine derivatives and their use as tachykinin antagonists
EP1083889B1 (en) * 1998-06-01 2003-12-10 Ortho-McNeil Pharmaceutical, Inc. Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases
DE10130020A1 (de) 2001-06-25 2003-12-04 Gruenenthal Gmbh Substituierte 1-Oxa-2,8-diaza-spiro[4.5]dec-2-en-derivate
WO2003010168A1 (fr) 2001-07-23 2003-02-06 Banyu Pharmaceutical Co., Ltd. Derive de 4-oxoimidazolidine-2-spiropiperidine
BR0309875A (pt) 2002-05-03 2007-04-10 Israel Inst For Biolog Res Isr métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
DE102004014296A1 (de) 2004-03-22 2005-10-06 Grünenthal GmbH Substituierte 1,4,8-Triazaspiro[4.5]decan-2-on-Verbindingen
DE102004014304A1 (de) 2004-03-22 2005-10-06 Grünenthal GmbH Substituierte 1,4,8- Triazaspiro[4,5]decan-2-on-Verbindungen
CA2566445C (en) * 2004-05-12 2016-02-02 The Government Of The United States As Represented By The Secretary, Department Of Health And Human Services Methods related to the treatment of neurodegenerative and inflammatory conditions
DE102005030051A1 (de) 2005-06-27 2006-12-28 Grünenthal GmbH Substituierte 1-Oxa-3,8-diazaspiro[4,5]-decan-2-on-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
AR057579A1 (es) 2005-11-23 2007-12-05 Merck & Co Inc Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
US8614324B2 (en) 2008-10-31 2013-12-24 Pain Therapeutics, Inc. Filamin A binding anti-inflammatory and analgesic
US20100280057A1 (en) * 2009-05-04 2010-11-04 Lindsay Burns Barbier Novel analgesic that binds filamin a
US8653068B2 (en) 2009-10-30 2014-02-18 Pain Therapeutics, Inc. Filamin A binding anti-inflammatory and analgesic
US8722851B2 (en) 2007-11-02 2014-05-13 Pain Therapeutics, Inc. Analgesia with minimal tolerance and dependence by a mu opioid receptor agonist that also binds filamin A
US20100279997A1 (en) * 2009-05-04 2010-11-04 Lindsay Burns Barbier Analgesic that binds filamin a
WO2010051497A1 (en) * 2008-10-31 2010-05-06 Pain Therapeutics, Inc. Filamin a binding anti-inflammatory and analgesic
US8580808B2 (en) 2009-10-30 2013-11-12 Pain Therapeutic, Inc. Filamin A-binding anti-inflammatory analgesic
US20100279996A1 (en) 2009-05-04 2010-11-04 Lindsay Burns Barbier Novel analgesic that binds filamin a
AU2010207486B2 (en) 2009-01-26 2013-03-07 Israel Institute For Biological Research Bicyclic heterocyclic spiro compounds
US20100280061A1 (en) 2009-05-04 2010-11-04 Lindsay Burns Barbier Novel analgesic that binds filamin a
TWI374662B (en) * 2009-05-18 2012-10-11 Novatek Microelectronics Corp Image processing circuit and method thereof
US8580809B2 (en) 2009-10-30 2013-11-12 Pain Therapeutics, Inc. Filamin A-binding anti-inflammatory analgesic
WO2014028755A1 (en) * 2012-08-16 2014-02-20 Pain Therapeutics, Inc. Benzazocine-ring compound inhibition of tau hyperphosphorylation

Similar Documents

Publication Publication Date Title
JP2023036695A5 (https=)
JP2022000421A5 (https=)
JP2015523385A5 (https=)
KR970704435A (ko) 헤테로시클릭 화합물의 도파민-D 리간드로서의 용도(Use of Heterocyclic Compounds as Dopamines-D Ligands)
NZ590784A (en) Pyrazolopyridine kinase inhibitors
ZA200403087B (en) MCH antagonists for the treatment of obesity.
RU98118568A (ru) Триарильные соединения
DE69733825D1 (de) Chinolin-derivate die den effekt von wachstumsfaktoren wie vegf vezögern
RU2000127751A (ru) Противоопухолевое средство
RU2003117476A (ru) Аминотиазолы и их применение в качестве антагонистов рецептора аденозина
JP2004523561A5 (https=)
PT85651B (pt) Processo de preparacao de novos derivados de quinolina substituidos e de composicoes farmaceuticas que os contem
JP2008515913A5 (https=)
RU2018120242A (ru) Хинолиновые соединения, способы их получения и их применения в качестве лекарственного средства, ингибирующего транспортер уратов
JPS6197228A (ja) ジヒドロピリジン類とａｃｅ阻害剤との配合物
PT1678162E (pt) Inibidor de p-glicoproteína, método para preparar o mesmo e composição farmacêutica compreendendo o mesmo
RU2009149518A (ru) Триазоло[1, 5-а]хинолины в качестве лигандов рецептора аденозина а3
RU2002103876A (ru) АМИНОБЕНЗОФЕНОНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ИНТЕРЛЕЙКИНА IL-1β И ФАКТОРА НЕКРОЗА ОПУХОЛЕЙ TNF-α
KR910004568A (ko) 치환 n-(퀴놀린-2-일-메톡시)벤질-술포닐우레아
US4758427A (en) Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone
RU2007112501A (ru) Бензимидазольные производные, содержащие их композиции, их получение и применение
RU2006117627A (ru) Новые применения в медицине соединений, обладающих антагонистической активностью по отношению к св1, и комбинированное лечение с применением этих соединений
US4442084A (en) Analgesic and myotonolytic preparations
WO1995024195A1 (en) New use of quinoline-3-carboxamide compounds
JP2005515169A5 (https=)